Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.8 |
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.8 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |